Keros Therapeutics (KROS) Current Taxes (2025)

Keros Therapeutics' (KROS) quarterly Current Taxes came in at $4.1 million in Q3 2025, down 34.39% on a QoQ basis from $6.3 million in Q2 2025.

Keros Therapeutics (KROS) Current Taxes (2025) Analysis & Trends

Keros Therapeutics (KROS) has 1 years of Current Taxes data on file, last reported at $4.1 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	49.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	76.32 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	76.36 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Keros Therapeutics	217.61 Mn	-40.00 Mn	-	-

Download Data